Search research articles
Contact Us
Filters
Showing results (61-70 of 195) with videos related to
Page
of 20
Sort By:
Advances in Therapy
|
November 30, 2019
Application of Dried Human Amnion Graft to Improve Post-Prostatectomy Incontinence and Potency: A Randomized Exploration Study Protocol
Dimitri Barski, Holger Gerullis, Thorsten Ecke, et al.
Journal of Cancer Research and Clinical Oncology
|
March 6, 2025
Impact of interdisciplinary tumor boards (ITB) and personalized treatment on survival outcomes in metastatic castration-resistant prostate cancer
Laura Lawaczeck, Anna Rüdiger, Jörg Hennenlotter, et al.
Cancers
|
October 14, 2022
Concomitant Use of Sulforaphane Enhances Antitumor Efficacy of Sunitinib in Renal Cell Carcinoma In Vitro
Igor Tsaur, Anita Thomas, Emine Taskiran, et al.
Life Sciences
|
February 2, 2016
Amygdalin delays cell cycle progression and blocks growth of prostate cancer cells in vitro
Jasmina Makarević, Igor Tsaur, Eva Juengel, et al.
Plos One
|
October 22, 2014
Amygdalin influences bladder cancer cell adhesion and invasion in vitro
Jasmina Makarević, Jochen Rutz, Eva Juengel, et al.
Cancers
|
January 21, 2022
Insulin-like Growth Factor-1 Influences Prostate Cancer Cell Growth and Invasion through an Integrin α3, α5, αV, and β1 Dependent Mechanism
Carolin Siech, Jochen Rutz, Sebastian Maxeiner, et al.
Cancers
|
June 7, 2019
Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro
Eva Juengel, Iyad Natsheh, Ramin Najafi, et al.
Oncotarget
|
January 5, 2018
HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells
Eva Juengel, Ramin Najafi, Jochen Rutz, et al.
World Journal of Urology
|
March 15, 2023
Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected
Gregor Duwe, Katharina Boehm, Maximilian Haack, et al.
International Journal of Molecular Sciences
|
February 24, 2024
Interleukin-1β/Interleukin (IL)-1-Receptor-Antagonist (IL1-RA) Axis in Invasive Bladder Cancer-An Exploratory Analysis of Clinical and Tumor Biological Significance
Marko Vukovic, Jorge M Chamlati, Jörg Hennenlotter, et al.
Page
of 20
Search research articles
Search
Showing results (61-70 of 195) with videos related to
Sort By:
Page
of 20
Advances in Therapy
|
November 30, 2019
Application of Dried Human Amnion Graft to Improve Post-Prostatectomy Incontinence and Potency: A Randomized Exploration Study Protocol
Dimitri Barski, Holger Gerullis, Thorsten Ecke, et al.
Journal of Cancer Research and Clinical Oncology
|
March 6, 2025
Impact of interdisciplinary tumor boards (ITB) and personalized treatment on survival outcomes in metastatic castration-resistant prostate cancer
Laura Lawaczeck, Anna Rüdiger, Jörg Hennenlotter, et al.
Cancers
|
October 14, 2022
Concomitant Use of Sulforaphane Enhances Antitumor Efficacy of Sunitinib in Renal Cell Carcinoma In Vitro
Igor Tsaur, Anita Thomas, Emine Taskiran, et al.
Life Sciences
|
February 2, 2016
Amygdalin delays cell cycle progression and blocks growth of prostate cancer cells in vitro
Jasmina Makarević, Igor Tsaur, Eva Juengel, et al.
Plos One
|
October 22, 2014
Amygdalin influences bladder cancer cell adhesion and invasion in vitro
Jasmina Makarević, Jochen Rutz, Eva Juengel, et al.
Cancers
|
January 21, 2022
Insulin-like Growth Factor-1 Influences Prostate Cancer Cell Growth and Invasion through an Integrin α3, α5, αV, and β1 Dependent Mechanism
Carolin Siech, Jochen Rutz, Sebastian Maxeiner, et al.
Cancers
|
June 7, 2019
Mechanisms behind Temsirolimus Resistance Causing Reactivated Growth and Invasive Behavior of Bladder Cancer Cells In Vitro
Eva Juengel, Iyad Natsheh, Ramin Najafi, et al.
Oncotarget
|
January 5, 2018
HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells
Eva Juengel, Ramin Najafi, Jochen Rutz, et al.
World Journal of Urology
|
March 15, 2023
Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected
Gregor Duwe, Katharina Boehm, Maximilian Haack, et al.
International Journal of Molecular Sciences
|
February 24, 2024
Interleukin-1β/Interleukin (IL)-1-Receptor-Antagonist (IL1-RA) Axis in Invasive Bladder Cancer-An Exploratory Analysis of Clinical and Tumor Biological Significance
Marko Vukovic, Jorge M Chamlati, Jörg Hennenlotter, et al.
Page
of 20